The Registry of Hyperbaric Oxygen Therapy Treated Patients
Description:
The goal of the Hyperbaric Oxygen Therapy Registry (HBOTR) for Wounds is to provide
comparative effectiveness data for patients and to understand whether clinical practice
guidelines are followed in the use of HBOT.
Hyperbaric Oxygen Therapy (HBOT) is the use of oxygen at greater than one atmosphere (sea
level) pressures and is administered by placing the entire patient in a pressurized vessel
and having the patient breathe 100% oxygen. The minimum treatment pressure with evidence to
support its use among the conditions approved by the Undersea and Hyperbaric Medical society
is 2.0 atmospheres absolute (2 ATA) which is an inspired partial pressure of oxygen of
approximately 1,520 mmHg. Hyperbaric treatments which provide less than 100% inspired oxygen
at the treatment pressure and/or which provide an inspired partial pressure of oxygen less
than 760 mmHg are not hyperbaric therapy. Topically applied oxygen is not hyperbaric oxygen
therapy. Oxygen is a drug with a well-defined dose response curve as well as acute and
chronic drug effects. HBOT also has side effects including oxygen toxicity to many organ
systems. The physiological effects of hyperbaric oxygen therapy are well studied.
Effectiveness in real world patients is the best current option to understand the role of
HBOT in wound healing.
Hospital based outpatient wound centers participating in the US Wound Registry agree to
provide data as part of quality initiatives and to meet their Stage 2 Meaningful use
criteria. The HBOTR is a subset of the USWR (Chronic Disease Registry) data. All patient data
from all participating hyperbaric centers are transmitted to the USWR where data are then
used as designated for benchmarking, to satisfy the requirements of PQRS for advanced
practitioners, and for data needed by the UHMS to respond to governmental agencies. Data used
for effectiveness research are HIPAA de-identified.
Condition:
Air or Gas Embolism
Treatment:
Start Date:
January 2005
Sponsor:
U.S. Wound Registry
For More Information:
https://clinicaltrials.gov/show/NCT02483650